Add Press Release About Us FAQ Login
PPWE, MASC, PWRM - Afternoon Stock highlights! from PennyToBuck.com
  Users Blogs
  Content Syndication
   Architecture
   Art and Entertainment
   Automobile
   Automotive
   Business
   Chemical
   Computer
   Computers
   Consumer
   Design
   Economy
   Education
   Employment And Careers
   Employment Opportunity
   Environment
   Events And Trade Shows
   Events and Tradeshows
   Gaming And Casinos
   Government
   Home And Family
   Industry Specific
   Industry Updates
   IndustrySpecific
   Insurance
   Interviews
   Legal And Law
   Lifestyle
   Machinery
   Maritime
   Medical
   Miscellaneous
   Non-profit
   Opinion and Editorial
   Others
   Politics
   Public Utilities
   Religion
   Science and Research
   Society
   Sports
   Teaching and Learning
   Technology
   Telecom
   Textile
   Trade
   Transportation
   Volunteer
PPWE, MASC, PWRM - Afternoon Stock highlights! from PennyToBuck.com

p-b2

 

 

 

chartstockalert

___

http://pennyomega.com/img/ppwe.png Proper Power & Energy, Inc. (PPWE.OB)

Proper Power & Energy, Inc. has announced the next stage of its Western U.S. operations. Proper Power met with the executives of Thrust Resources Inc. and EQ Resources Inc. in Dallas, Texas on January 20, 2011. The meeting focused on a joint venture for the Central Utah Prospect between the Companies. This was the initial meeting between Clint Brower, CEO and Chairman of EQ Resources, and Andrew Kacic, the newly named President of Proper Power.

The next steps will be circulating a memorandum of understanding followed upon definitive agreements. "We look forward to expedite future discussions of both Companies working together to mutually reach our Utah objectives," stated Andrew Kacic.

In other company news, Proper Power's wholly owned subsidiary, American Resources, Inc. (ARI), has begun production on its 87.5 acres in Western Kentucky.

ARI has completed the re-work on all 4 wells, with those wells online and pumping. "This is an exciting day for us," stated Proper Power President, Andrew Kacic. "This is the beginning of production for Proper Power in Kentucky, and we look forward to increasing our presence."

Additionally, Proper Power announced this month that it has restructured its executive management team and entered into a strategic alliance.

Andrew J. Kacic will replace Joseph Abdo as President of Proper Power. Mr. Kacic brings more than 32 years of progressive experience as a chief executive in oil and gas, investment banking, insurance services and public securities. Mr. Kacic was the founder and president of American Resources of Delaware, Inc. and its subsidiary Southern Gas Company, successfully taking assets from $220,000 to more than $40 million in less than 4 years. Mr. Abdo will remain the Chief Executive Officer and Chairman of the Board.

Concurrently to the management restructuring, Proper Power has entered into a strategic alliance with Douglas Kiggins, founder of Mayo Energy Partners. Mr. Kiggins will assist Mr. Kacic in the development of the Company's Utah asset, with the target goal of drilling the first exploratory well in Utah by third Quarter 2011. Mr. Kiggins has participated in the drilling and development of over 250 oil and gas wells in Texas, Oklahoma and Colorado, with the deepest well reaching a total depth over 21,000 feet.

"The Company is now postured to accelerate the development of both Utah and Kentucky in the first Quarter 2011," Mr. Abdo stated.

Proper Power & Energy, Inc. was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.

To learn more about PPWE visit: http://properpower.com

*****

Material Sciences Corporation (NASDAQ:MASC), a leading provider of material-based solutions for acoustical and coated applications, today announced that the company's board of directors has authorized the repurchase of up to one million shares of common stock. These one million shares are in addition to the 114,081 shares remaining available for repurchase under the Board's January 7, 2008 authorization. The share repurchases will be made from time to time at MSC's discretion, subject to market conditions and other factors, and will be funded with internally generated cash. As of January 27, 2011, MSC had 12,909,133 shares outstanding.

Material Sciences Corporation, together with its subsidiaries, engages in the design, manufacture, and marketing of material-based solutions for acoustical and coated applications in the United States and internationally. It offers acoustical material-based solutions, which include multilayer composites consisting of metals, polymeric coatings, and other materials used to manage noise and vibration in automotive body panel laminate parts, brake dampers, engine parts, appliances, and computer disk drives, as well as heating, ventilation, and air conditioning products. The company also provides coated metal material-based solutions that comprise painted, electrogalvanized protective, decorative, and functional coatings applied to coils of metals for automotive fuel tanks, building products, gaskets, appliances, and lighting fixtures. Material Sciences Corporation primarily serves customer in the automotive, appliance, building and construction, lighting, and electronic markets. The company markets its products, services, and technologies through sales and marketing organization, as well as through agents and licensees. Material Sciences has strategic alliances with Hae Won Steel to produce Quiet Steel and other decorative laminate products. The company was founded in 1971 and is headquartered in Elk Grove Village, Illinois.

*****

Power3 Medical Products, Inc. (PWRM.OB)

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

"We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now," stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3. "We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

To learn more about PWRM visit: http://www.Power3Medical.com

___

*************************************************************

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

*************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) received 1,000,000 shares of free trading shares from a third party (Mohamad Nehmeh) for two (2) weeks of advertisement services for Proper Power & Energy, Inc. (PPWE.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Terms     |    Privacy     |    Contact us     |    Site Map     |    Links
Sitemap   1 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 
62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 
92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 
122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 
182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 
212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 
242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 
272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 
302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 
332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 
362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 
392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 
422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 
452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 
482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 
512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 
542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 
572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 
602 603 604 605 606 607 608 609 610 611 612 613 614 
This website disclaims any content found in these news releases or articles. Issuers of news releases or articles are solely responsible for the accuracy of their content. If you have any questions regarding information in these news releases, please contact the issuers of the press releases.
© Copyright @ 2005. All rights Reserved. Use of our service is protected by our Privacy policy and Terms of Service.